Skip to main content

letter

. 1993 Oct 9;307(6909):939–940. doi: 10.1136/bmj.307.6909.939-d

Diagnosis and management of systemic lupus erythematosus. Thalidomide modifies disease.

PMCID: PMC1679083 PMID: 8241877

940

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burrows N. P., Walport M. J., Hammond A. H., Davey N., Jones R. R. Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide. Br J Dermatol. 1991 Jul;125(1):62–67. doi: 10.1111/j.1365-2133.1991.tb06042.x. [DOI] [PubMed] [Google Scholar]
Knop J., Bonsmann G., Happle R., Ludolph A., Matz D. R., Mifsud E. J., Macher E. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol. 1983 Apr;108(4):461–466. doi: 10.1111/j.1365-2133.1983.tb04600.x. [DOI] [PubMed] [Google Scholar]
Naafs B., Bakkers E. J., Flinterman J., Faber W. R. Thalidomide treatment of subacute cutaneous lupus erythematosus. Br J Dermatol. 1982 Jul;107(1):83–86. doi: 10.1111/j.1365-2133.1982.tb00294.x. [DOI] [PubMed] [Google Scholar]
Venables P. J. Diagnosis and treatment of systemic lupus erythematosus. BMJ. 1993 Sep 11;307(6905):663–666. doi: 10.1136/bmj.307.6905.663. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES